When and how should we screen for hereditary hemochromatosis?;Quand et comment dépister une hémochromatose génétique?

Revue du Rhumatisme (Edition Francaise)

Volumn 70, Issue 7, 2003, Pages 573-581

  Chalès, Gérard ^a   Guggenbuhl, Pascal ^a  

^a SERVICE DE RHUMATOLOGIE   (France)

Author keywords

Diagnosis; Hemochromatosis; HFE gene; Iron overload; Screening

Indexed keywords

IRON; TRANSFERRIN;

ARTHRALGIA; ASTHENIA; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DISEASE SEVERITY; EARLY DIAGNOSIS; HEART; HEMOCHROMATOSIS; HOMOZYGOSITY; HUMAN; INBORN ERROR OF METABOLISM; IRON ABSORPTION; IRON INTAKE; IRON METABOLISM; IRON OVERLOAD; LIVER; PANCREAS; REVIEW; SCREENING TEST; TRANSFERRIN BLOOD LEVEL;

EID: 10944246578     PISSN: 11698330     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1169-8330(03)00064-4     Document Type: Short Survey

References (113)

1. International Consensus EASL. Conference on Haemochromatosis. J Hepatol 2000;33:485-504.
2. Brissot P, Deugnier Y. Haemochromatosis. In: Bircher J, Benhamou JP, McIntyre N, Rizetto M, Rodes J, editors. Oxford Texbook of Clinical Hepatololgy. 2nd ed. Oxford: University Press; 1999. p. 1379-91.
3. Simon M, Pawlotsky Y, Bourel M, Fauchet R, Genetet B. Hémochromatose idiopathique : maladie associée à l'antigène tissulaire HL-A3. Nouv Presse Méd 1975;4:1432.
4. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
5. Zhou XY, Tomatsu S, Flemming RE, Parkkila S, Waheed A, Jiang J, et al. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci 1998;95:2492-7.
6. Lebron JA, West AP, Bjorkman PJ. The hemochromatosis protein HFE competes with transferrin for binding to the transferrin receptor. J Mol Biol 1999;294:239-45.
7. Fleming RE, Sly WS. Mechanisms of iron accumulation in hereditary hemochromatosis. Annu Rev Physiol 2002;64:663-80.
8. Townsend A, Drakesmith H. Role of HFE in iron metabolism, hereditary haemochromatosis, anaemia of chronic disease and secondary iron overload. Lancet 2002;359:786-90.
9. Waheed A, Grubb JH, Zhou XJ, Tomatsu S, Fleming RE, Costaldi ME, et al. Regulation of transferrin-mediated iron uptake by HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci 2002;99:3117-22.
10. Trinder D, Olynyk JK, Sly WS, Morgan EH. Iron uptake from plasma transferrin by the duodenum is impaired in the HFE knockout mouse. Proc Natl Acad Sci 2002;99:5622-6.
11. Parkkila S, Niemela O, Britton RS, Fleming RE, Waheed A, Bacon BR, et al. Molecular aspects of iron absorption and HFE expression. Gastroenterology 2001;121:1489-96.
12. Pietrangelo A. Physiology of iron transport and the hemochromatosis gene. Am J Physiol Gastrointest Liver Physiol 2002;282:G403-14.
13. Rolfs A, Bonkovsky HL, Kohlroser JG, McNeal K, Sharma A, Berger UV, et al. Intestinal expression of genes involved in iron absorption in humans. Am J Physiol Gastrointest Liver Physiol 2002; 282:0598-607.
14. Andrews NC. Metal transporters and disease. Curr Opin Chem Biol 2002;6:181-6.
15. Powell LW, Subramaniam VN, Yapp TR. Haemochromatosis in the new millennium. J Hepatol 1999;32(suppl. 1):48-62.
16. Brissot P, Guyader D, Pigeon C, Laine F, Loréal O. Physiopathologie et diagnostic de l'hémochromatose. Médecine Thérapeutique 2001;7:350-5.
17. Dupic F, Fruchon S, Bensaid M, Borot N, Radosavljevic M, Loreal O, et al. Inactivation of the hemochromatosis gene differentially regulates duodenal expression of iron-related mRNAs between mouse strains. Gastroenterology 2002;122:745-51.
18. Philpott CC. Molecular aspects of iron absorption: insights into the role of HFE in hemochromatosis. Hepatology 2002;35:993-1001.
19. Krause A, Neitz S, Magert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 2000;480:147-50.
20. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001;276:7806-10.
21. Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 2001;276:7811-9.
22. Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, et al. Lack of hepcidin gene espression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci 2001;98:8780-5.
23. Nicolas G, Bennoun M, Porteu A, Mativet S, Beaumont C, Grandchamp B, et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci 2002;99:4596-601.
24. Lee PL, Gelbart T, West C, Halloran C, Felitti V, Beutler E. A study of genes that modulate the expression of hereditary hemochromatosis: Transferrin Receptor-1, Ferroportin, Ceruloplasmin, Ferritin light and heavy chains, Iron Regulatory Proteins (IRP) -1 and -2 and Hepcidin. Blood Cells Mol Dis 2001;27:783-802.
25. Fletcher LM, Halliday JW. Haemochromatosis: understanding the mechanism of disease and implications for diagnosis and patient management following the recent cloning of novel genes involved in iron metabolism. J Intern Med 2002;251:181-92.
26. Roy CN, Andrews NC. Recent advances in disorders of iron metabolism: mutations, mechanisms and modifiers. Hum Mol Genet 2001;10:2181-6.
27. Fleming RE, Sly WS. Ferroportin mutation in autosomal dominant hemochromatosis: loss of function, gain in understanding. J Clin Invest 2001;108:521-2.
28. Britton RS, Fleming RE, Parkkila S, Waheed A, Sly WS, Bacon BR. Pathogenesis of hereditary hemochromatosis: genetics and beyond. Semin Gastrointest Dis 2002;13:68-79.
29. Simon M, Bourel M, Genetet B, Fauchet R. Idiopathic hemochromatosis, Demonstration of recessive transmission and early detection by family HLA typing. New Engl J Med 1977;297:1017-21.
30. Moirand R, Jouanolle AM, Brissot P, Le Gall JY, David V, Deugnier Y. Phenotypic expression of HFE mutations: a French study of 1110 unrelated iron-overload patients and relatives. Gastroenterology 1999;116:372-7.
31. Deugnier Y, David V. Génétique et épidé miologie des hémochromatoses génétiques. Médecine Thérapeutique 2001;7:346-9.
32. Girelli D, Bozzini C, Roetto A, Alberti F, Daraio F, Colombari R, et al. Clinical and pathologic findings in hemochromatosis type 3 due to a novel mutation in Transferrin Receptor 2 gene. Gastroenterology 2002;122:1295-302.
33. Bottomley SS. Secondary iron overload disorders. Semin Hematol 1998;35:77-86.
34. Hanson EH, Imperatore G, Burke W. HFE gene and hereditary hemochromatosis: a HuGE review. Am J Epidemiol 2001;154:193-206.
35. Steinberg KK, Cogswell ME, Chang JC, Caudill SP, McQuillan GM, Bowman BA, et al. Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States. JAMA 2001;285: 2216-22.
36. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996;110:1107-19.
37. Fracanzani AL, Conte D, Fraquelli M, Taioli E, Mattioli M, Losco A, et al. Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease. Hepatology 2001; 33:647-51.
38. Bathum L, Christiansen L, Nybo H, Andersen-Ran berg K, Gaist D, Jeune B, et al. Associations of mutations in the hemochromatosis gene with shorter life expectancy. Arch Int Med 2001;161:2441-4.
39. Beutler E, Felitti VJ. The C282Y mutation does not shorten life span. Arch Intern Med 2002;162:1196-7.
40. Milman N, Pedersen P, Steig T, Byg KE, Graudal N, Fenger K. Clinically overt hereditary hemochromatosis in Denmark 1948-1985: epidemiology, factors of significance for long-term survival and causes of death in 179 patients. Ann Hematol 2001;80:737-44.
41. Wojcik JP, Speechley MR, Kertesz AE, Chakrabarti S, Adams PC. Natural history of C282Y homozygotes for hemochromatosis. Can J Gastroenterol 2002;16:297-302.
42. Deugnier Y, Moirand R. Surcharges en fer et santé publique. Bull Acad Natle Méd 2000;184:365-76.
43. Brissot P, Moirand R, Guyader D, Loréal O, Turlin B, Deugnier Y. Hemochromatosis after the gene discovery: revisiting the diagnostic strategy. J Hepatol 1998;28:14-8.
44. Powell LW. Diagnosis of hemochromatosis. Semin Gastrointest Dis 2002;13:80-8.
45. Moirand R, Guillygomarc'h A, Brissot P, Deugnier Y. Diagnostic et traitement des hémochromatoses génétiques. Rev Prat 2000;50:977-82.
46. McDonnell SM, Preston BL, Jewell SA, Barton JC, Edwards CQ, Adams PC, et al. A survey of 2851 patients with hemochromatosis: symptoms and response to treatment. Am J Med 1999;106:619-24.
47. Moirand R, Adams PC, Bicheler V, Brissot P, Deugnier Y. Clinical features of genetic hemochromatosis in women compared with men. Ann Intern Med 1997;127:105-10.
48. Bothwell TH, MacPhail AP. Hereditary hemochromatosis: etiologic, pathologic and clinical aspects. Semin Hematol 1998;35:55-71.
49. Powell LW, Leggett BA, Crawford DHG. Hemochromatosis and iron storage disorders. In: Schiff ER, Sorell MF, Maddrey WC, editors. Schiff's diseases of the liver. 8th ed. Philadelphia: Lippincott-Raven; 1999. p. 1107-30.
50. Bacon BR, Sadiq SA. Hereditary hemochromatosis: presentation and diagnosis in the 1990s. Am J Gastroenterol 1997;92:784-9.
51. Adams PC, Valberg LS. Evolving expression of hereditary hemochromatois. Semin Liver Dis 1996;16:47-54.
52. Faraawi R, Harth M, Kertesz A, Bell D. Arthritis in hemochromatosis. J Rheumatol 1993;20:448-52.
53. Axford JS. Rheumatic manifestations of hemochromatosis. Baillieres Clin Rheumatol 1991;5:351-65.
54. Inês LS, da Silva JAP, Malcata AB, Porto AL. Arthropathy of genetic hemochromatosis: a major and distinctive manifestation of the disease. Clin Exp Rheumatol 2001;19:98-102.
55. Pawlotsky Y, Le Dantec P, Moirand R, Guggenbuhl P, Jouanolle AM, Catheline M, et al. Elevated parathyroid hormone 44-68 and osteoarticular changes in patients with genetic hemochromatosis. Arthritis Rheum 1999;42:799-806.
56. Adams PC, Kertesz AE, Valberg LS. Clinical presentation of hemochromatosis: a changing scene. Am J Med 1991;90:445-9.
57. Kempis von J. Arthropathy in hereditary hemochromatosis. Curr Opin Rheumatol 2001;13:80-3.
58. Dymock IW, Hamilton EBD, Laws JW, Williams R. Arthropathy of haemochromatosis, Clinical and radiological analysis of 63 patients with iron overload. Ann Rheum Dis 1970;29:469-76.
59. Adams PC, Deugnier Y, Moirand R, Brissot P. The relationship between iron overload, clinical symptoms and age in 410 patients with genetic hemochromatosis. Hepatology 1997;25:162-6.
60. Adams PC, Speechley M. The effect of arthritis on the quality of life in hereditary hemochromatosis. J Rheumatol 1996;23:707-10.
61. Brissot P. Clinical spectrum of hepatic disease in hemochromatosis. In: Barton JC, Edwards CQ, editors. Hemochromatosis, Genetic, pathophysiology, diagnosis and treatment. Cambridge: University Press; 2000. p. 250-7.
62. Dubois-Lagorgue D, Larger E, Timsit J. Le diabète sucré est-il une condition suffisante pour suspecter une hémochromatose ? Diabetes Metab 2000;26:318-21.
63. Hetet G, Elbaz A, Gariepy J, Nicaud V, Arveiler D, Morrison C, et al. Association studies between haemochromatosis gene mutations and the risk of cardiovascular diseases. Eur J Clin Invest 2001;31:382-8.
64. Jäger HJ, Mehring UM, Götz GF, Neise M, Erlemann R, Kapp HJ, et al. Radiological features of the visceral involvement of hemochromatosis. Eur Radiol 1997;7:1199-206.
65. Rull M, Schumacher Jr HR. The arthropathy of hemochromatosis. In: Barton JC, Edwards CQ, editors. Hemochromatosis, Genetic, pathophysiology, diagnosis and treatment. Cambridge: University Press; 2000. p. 258-67.
66. Chalès G, Guggenbuhl P. Ostéoporose de l'hé mochromatose génétique. Rev Rhum [Ed Fr] 2001;68:749-51.
67. Deugnier Y, Mendler MH, Turlin B, Guillygomarc'h A, Moirand R. Hépatosidérose métabolique. Gastroenterol Clin Biol 2000;24:B79-87.
68. McCarthy GM, Rosenthal AK, Carrera GF. Hemochromatosis-like arthropathy in diabetes mellitus without hemochromatosis. J Rheumatol 1996;23:1453-6.
69. Fletcher LM, Dixon JL, Purdie DM, Powell LW, Crawford DHG. Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis. Gastroenterology 2002;122:281-9.
70. Thorburn D, Curry G, Spooner R, Spence E, Oien K, Halls D, et al. The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C. Gut 2002;50:248-52.
71. Koziol JA, Ho NJ, Felitti VJ, Beutler E. Reference centiles for serum ferritin and percentage of transferrin saturation, with application to mutations of the HFE gene. Clin Chem 2001;47:1804-10.
72. Deugnier YD, Turlin B. Iron and hepatocellular carcinoma. J Gastroenterol Hepatol 2001;16:491-4.
73. Guyader D, Jacquelinet C, Moirand R, Turlin B, Mendler MH, Chaperon J, et al. Non invasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology 1998;115:929-36.
74. Bacon BR, Powell LW, Adams PC, Kresina TF, Hoofnagle JH. Molecular medicine and hemochromatosis: at the crossroads. Gastroenterology 1999;116:193-207.
75. Gochee PA, Powell LW, Cullen DJ, Du Sart D, Rossi E, Olynyk JK. A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation. Gastroenterology 2002;122: 646-51.
76. Pietrangelo A, Montosi G, Totaro A, Garutti C, Conte D, Cassanelli S, et al. Hereditary hemochromatosis in adults without mutations in the hemochromatosis gene. N Engl J Med 1999;341:725-32.
77. Adams PC, Gregor JC, Kertesz AE, Valberg LS. Screening blood donors for hereditary hemochromatosis: decision analysis model based on a 30-years database. Gastroenterology 1995;109:177-88.
78. Yaouanq J, Feingold J, Lacombe D, Société Française de Génétique Humaine. Commission «Pratique de la Génétique », Fiche de synthèse des données scientifiques utiles au conseil génétique, Hémochromatose. Ann Genet 1999;42:234-40.
79. Adams PC. Implications of genotyping of spouses to limit investigation of children in genetic hemochromatosis. Clin Genet 1998;53: 176-8.
80. Adams PC. Population screening for haemochromatosis. Gut 2000; 46:301-3.
81. Wilson JMG, Jungner G. Principes et pratique du dépistage des maladies. Genève: Organisation Mondiale de la Santé; 1970.
82. Brittenham GM, Franks AL, Rickles FR. Research priorities in hereditary hemochromatosis. Ann Intern Med 1998;129:993-6.
83. Allen K, Williamson R. Should we genetically test every one for haemochromatosis? J Med Ethics 1999;25:209-14.
84. Niederau C, Strohmeyer G. Strategies for early diagnosis of haemochromatosis. Eur J Gastroenterol Hepatol 2002;14:217-21.
85. Adams PC, Valberg LS. Screening blood donors for hereditary hemochromatosis, Decision analysis model comparing genotyping to phenotyping. Am J Gastroenterol 1999;94:1593-600.
86. Asberg A, Hveem K, Thorstensen K, Ellekjter E, Kannelønning K, Fjøsne U, et al. Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol 2001;36:1108-15.
87. Worwood M. What is the role of genetic testing in diagnosis of haemochromatosis? Ann Clin Biochem 2001;38:3-19.
88. Sham RL, Ou CY, Cappuccio J, Braggins C, Dunnigan K, Phatak PD. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases. Blood Cells Mol Dis 1997;23: 314-20.
89. Crawford DHG, Jazwinska EC, Cullen LM, Powell LW. Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation. Gastroenterology 1998;114:1003-8.
90. Brissot P, Moirand R, Jouanolle AM, Guyader D, Le Gall JY, Deugnier Y, et al. A genotypic study of 217 unrelated probands diagnosed as "genetic hemochromatosis" on "classical" phenotypic criteria. J Hepatol 1999;30:588-93.
91. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. New Engl J Med 1999;341:718-24.
92. Willis G, Wimperis JZ, Lonsdale R, Fellows IW, Watson MA, Skipper LM, et al. Incidence of liver disease in people with HFE mutations. Gut 2000;46:401-4.
93. McCullen MA, Crawford DHG, Hickman PE. Sreening for hemochromatosis. Clin Chim Acta 2002;315:169-86.
94. McLaren CE, McLachlan GJ, Halliday JW, Webb SI, Leggett BA, Jazwinska EC, et al. Distribution of transferrin saturation in an Australian population: relevance to the early diagnosis of hemochromatosis. Gastroenterology 1998;114:543-9.
95. Tavill AS. Diagnosis and management of hemochromatosis. Hepatology 2001;33:1321-8.
96. Ludwig J, Hashimoto E, Porayko MK, Moyer TP, Baldus WP. Hemosiderosis in cirrhosis. Gastroenterology 1997;112:882-8.
97. McGrath JS, Deugnier Y, Moirand R, Jouanolle AM, Chakrabarti S, Adams PC. A nomogram to predict C282Y hemochromatosis. J Lab Clin Med 2002;140:6-8.
98. Burke W, Thomson E, Khoury MJ, McDonnell SM, Press N, Adams PC, et al. Hereditary hemochromatosis, Gene discovery and its implications for population-based screening. JAMA 1998;280:172-8.
99. Adams PC, Chakrabarti S. Genotypic/Phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria. Gastroenterology 1998;114:319-23.
100. Beutler E, Felitti V, Gelbart T, Ho N. The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic. Ann Intern Med 2000;133:329-37.
101. Jackson HA, Carter K, Darke C, Guttridge MG, Ravine D, Hutton RD, et al. HFE mutations, iron deficiency and overload in 10 500 blood donors. Br J Haematol 2001;114:474-84.
102. Burke W, Imperatore G, McDonnell SM, Baron RC, Khoury MJ. Contribution of different HFE genotypes to iron overload disease: a pooled analysis. Genet Med 2000;2:271-7.
103. Agence Nationale d'Accréditation et d'Évaluation en Santé. Évaluation clinique et économique : intérêt du dépistage de l'hémochromatose en France. Paris: Anaes; juin 1999.
104. Adams PC. Nonexpressing homozygotes for C282Y hemochromatosis: minority or majority of cases? Mol Genet Metab 2000; 71:81-6.
105. Adams PC. Population screening for hemochromatosis: are we finding people with a disease or a biochemical curiosity? Semin Gastrointest Dis 2002;13:89-94.
106. Bassett ML, Leggett BA, Halliday JW, Webb S, Powell LW. Analysis of the cost of population screening for haemochromatosis using biochemical and genetic markers. J Hepatol 1997;27:517-24.
107. Eyon E, Frank EL. Hereditary hemochromatosis since discovery of the HFE gene. Clin Chem 2001;47:1147-56.
108. Lloyd FJ, Reyna VF, Whalen P. Accuracy and ambiguity in counseling patients about genetic risk. Arch Intern Med 2001;161:2411-3.
109. Bradley LA, Haddow JE, Palomaki GE. Population screening for hemochromatosis: expectations based on a study of relatives of symptomatic probands. J Med Screen 1996;3:171-7.
110. Bulaj ZJ, Ajioka RS, Phillips JD, LaSalle BA, Jorde LB, Griffen LM, et al. Disease-related conditions in relatives of patients with hemochromatosis. N Engl J Med 2000;343:1529-35.
111. Moirand R. Traitement de l'hémochromatose. Médecine Thérapeutique 2001;7:356-60.
112. Willis G, Scott DGI, Jennings BA, Smith K, Bukhari M, Wimperis JZ. HFE mutations in an inflammatory arthritis population. Rheumatology 2002;41:176-9.
113. Waalen J, Felitti V, Gelbart T, Ho NJ, Beutler E. Prevalence of hemochromatosis-related symptoms among individuals with mutations in the HFE gene. Mayo Clin Proc 2002;77:522-30.